Association study of PCSK9 SNPs (rs505151 & rs562556) and their haplotypes with CVDs in Indian population

Ann Hum Biol. 2023 Feb;50(1):56-62. doi: 10.1080/03014460.2023.2171121.

Abstract

Background: Cardiovascular disease (CVD) has emerged as the most prevalent cause of death in India. Pro-protein Convertase Subtilisin/Kexin Type 9 (PCSK9) gene has been found to be associated with lipid levels and a biomarker for susceptibility of CVD.

Aim: To study the association of PCSK9 SNPs rs505151 & rs562556 and their haplotypes with CVDs in the Indian population.

Subjects & methods: The present study comprised of 102 angiographically proven CVD patients & 100 healthy subjects. To study polymorphism, Polymerase Chain Reaction and Restriction Fragment Length Polymorphism (PCR-RFLP) method was used. Biochemical parameters were analysed by enzymatic methods or automated analysers. Haplotype analysis was done using SHEsis software.

Results: The dominant genetic model with an odds ratio (confidence interval) of 4.71 (2.59 - 8.5), (p value = .0001), shows the risk of CVDs. However, rs562556 (I474V) variant was not found to be associated with clinical parameters and risk of CVDs (p value >.05). Out of four haplotypes, H3 (G-A) was found to be associated with the CVDs (OR- 3.137, p value = .0001).

Conclusion: This study concludes that G allele of rs505151 SNP (PCSK9) and the H3 (G-A) haplotype of rs505151 & rs562556 were found to be risk factors for CVDs in the Indian population.

Keywords: CVD (cardiovascular disease); PCSK9 SNP (single nucleotide polymorphism); TC (total cholesterol); low-density lipoprotein.

MeSH terms

  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / genetics
  • Cholesterol, LDL
  • Haplotypes
  • Humans
  • Polymorphism, Single Nucleotide
  • Proprotein Convertase 9* / genetics
  • Subtilisin / genetics

Substances

  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Subtilisin
  • Cholesterol, LDL